Orphenadrine Citrate
Product Images NDC 53002-5430

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 53002-5430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Ccdf0ccb 14f9 46c3 Bc8c 84a8b0cb48c8 01)

Chemical structure diagram showing two distinct molecular structures side by side. The left structure includes a phenyl ring and ether linkage, while the right structure depicts a citrate molecule with multiple hydroxyl and carboxyl groups. This represents the chemical structure of orphenadrine citrate, the active ingredient in the product.*

FDA Label Image

Label Image (Lbl530025430)

ORPHENADRINE CITRATE 100MG x 20 tablets bottle label from RPK Pharmaceuticals, Inc. The label indicates the medication is a generic muscle relaxant with instructions to take one tablet twice daily or as directed. The label includes prescription-only designation, the National Drug Code (NDC) 53002-5430, lot and expiration data, and space for patient and prescriber information. The packaging is white with black text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.